| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |